Stock listing

Arrowhead Pharmaceuticals, Inc.

Selected listing: HDP1 · BX · CHF · CH

Arrowhead Pharmaceuticals, Inc. (BX Swiss: HDP1), Health Technology. Latest release Oct 7, 2026: Arrowhead Pharmaceuticals Granted Entry in the FDA STAR Pilot…

HDP1:BXCHFCHUpdated October 9, 2026

Ticker: BX Swiss: HDP1
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: BX Swiss
Currency: CHF

Latest news from Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals Granted Entry in the FDA STAR Pilot Program for Plozasiran in Severe Hypertriglyceridemia

October 7, 2026

Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies

September 29, 2026

Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia

September 15, 2026

Arrowhead Pharmaceuticals to Participate in Upcoming September 2026 Investor Conferences

September 3, 2026

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia

August 30, 2026

All Arrowhead Pharmaceuticals, Inc. news →

Events

Replays

Arrowhead Pharmaceuticals, Inc. (ARWR) Q3 2026 Earnings Call
Tue, Aug 04, 2026 · 04:30 PM ET
Watch
Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
Watch
Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2026 Earnings Call
Thu, Feb 05, 2026 · 04:30 PM ET
Watch

Research Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. company profile

View the public company page for Arrowhead Pharmaceuticals, Inc. on 6ix.

Arrowhead Pharmaceuticals, Inc. news

Read company news and market updates connected to Arrowhead Pharmaceuticals, Inc..

Arrowhead Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Arrowhead Pharmaceuticals, Inc..